Skip to main content

Table 1 Trial registration data

From: Leveraging social media to increase lung cancer screening awareness, knowledge and uptake among high-risk populations (The INSPIRE-Lung Study): study protocol of design and methods of a community-based randomized controlled trial

Data Category

Information

Primary registry and trial identifying number

ClinicalTrials.gov NCT05824273

Date of registration in primary registry

10 April, 2023

Source of monetary or material support

National Cancer Institute R01CA263662

Primary sponsor

Hackensack Meridian Health

Collaborator

National Cancer Institute (NCI)

Contact for public queries

Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN [lisa.carterbawa@hmh-cdi.org]

Contact for scientific queries

Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, Center for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ, USA

Public title

The INSPIRE-Lung Study

Scientific title

Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations

Countries of recruitment

USA

Health problem studied

Lung cancer screening

Intervention(s)

Intervention: computer-tailored health communication and decision support tool (LungTalk)

Comparator/attention control: non-tailored lung cancer screening video

Key inclusion and exclusion criteria

Ages eligible for study: 50–80 years; Sexes eligible for study: both; Accepts Healthy Volunteers: Yes

Inclusion criteria: ≥ 20 pack-year smoking history, individuals who currently smoke or quit smoking within the past 15 years

Exclusion criteria: have previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed, have been diagnosed with lung cancer

Study type

Interventional

Allocation: randomized; Intervention model: parallel assignment; Masking: none

Date of first enrollment

June 1, 2023 (anticipated)

Target sample size

500

Recruitment status

Not yet recruiting

Primary outcome(s)

Reach (reaching screening-eligible individuals via social media)

Effectiveness of LungTalk

Knowledge of Lung Cancer & Screening

Screening Uptake (time frame: 6 months)

Key secondary outcomes

Occurrence of a Patient-Clinician Discussion

Lung Cancer Screening Health Beliefs (perceived risk, perceived benefits, perceived barriers, self-efficacy)